Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / Ordinary Shares, par value $0.000006 per share
-
Shares outstanding
-
1,091,129,524
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
10,354,516
-
Shares change
-
+1,174,184
-
Total reported value, excl. options
-
$219,827,000
-
Value change
-
+$19,200,370
-
Number of buys
-
14
-
Number of sells
-
-33
-
Price
-
$21.23
Significant Holders of Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) as of Q4 2017
55 filings reported holding ZLAB - Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share as of Q4 2017.
Zai Lab Ltd - Ordinary Shares, par value $0.000006 per share (ZLAB) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,354,516 shares
of 1,091,129,524 outstanding shares and own 0.95% of the company stock.
Largest 10 shareholders include FMR LLC (4,276,524 shares), GILDER GAGNON HOWE & CO LLC (917,123 shares), Myriad Asset Management Ltd. (890,900 shares), ORBIMED ADVISORS LLC (658,160 shares), PRICE T ROWE ASSOCIATES INC /MD/ (556,100 shares), Segantii Capital Management Ltd (382,769 shares), Cormorant Asset Management, LLC (333,166 shares), Vivo Capital, LLC (317,567 shares), Rock Springs Capital Management LP (295,000 shares), and Marshall Wace North America L.P. (261,475 shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.